How is Cuvitru administered?
Cuvitru (immune globulin subcutaneous, human 20%) is infused under the skin and will initially be given by your doctor in their office. You and your caregiver may be taught to give Cuvitru at home by your doctor or nurse, and you will practice with them for the first few treatments.
Cuvitru is an Immune Globulin Subcutaneous (Human) 20% Solution used as replacement therapy for primary humoral immunodeficiency (PI) in adult and pediatric patients two years of age and older.
- Cuvitru is used in patients who do not have enough antibodies in their blood which leads to a weak immune system and frequent infections.
- Regular and sufficient doses of Cuvitru can raise low immunoglobulin levels in your blood to normal levels.
- Your doctor will determine the correct dose and how often you should receive Cuvitru.
- Do not use Cuvitru at home until you get instructions and training from
your healthcare professional. Cuvitru may be infused into the abdomen (stomach) area, thighs, upper arms, or lower back area.
Review the "Detailed Instructions for Administration for Patients" found in the Patient Counseling Information for more detailed information and diagrams. If you need a copy of the Patient Information, ask your doctor, pharmacist or other healthcare provider.
This is not all the information you need to know about Cuvitru for safe and effective use and does not take the place of talking to your doctor about your treatment. Review the full Cuvitru information here, and discuss this information and any questions you have with your doctor or other health care provider.
References
- Cuvitru. (immune globulin subcutaneous) [product information]. Baxalta US Inc.
Lexington, MA. Accessed March 4, 2021 at https://www.shirecontent.com/PI/PDFS/Cuvitru_USA_ENG.PDF
Related medical questions
Drug information
- Cuvitru Information for Consumers
- Cuvitru prescribing info & package insert (for Health Professionals)
- Side Effects of Cuvitru (detailed)
- Cuvitru user reviews (13)
Related support groups
- Cuvitru (1 questions, 3 members)
- Primary Immunodeficiency Syndrome (2 questions, 25 members)